Skip to main content
    N

    NRC Health (NRC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $26.33
    -0.23 (-0.87%)

    Market Cap: $563.64M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    NRC Health (NRC) Financials: Revenue, Profit and Cash Flow

    Updated Oct 27, 2026. Financial statements from company filings, amounts in US dollars.

    NRC Health reported revenue of $137.39M for the fiscal year ended Dec 31, 2025, down 4.0% from the year before. That year, net income was $11.60M with a net margin of 8.4%, operating cash flow was $26.45M and free cash flow was $15.74M. The quarter ended Sep 30, 2026 had revenue of $38.40M and net income of $4.70M.

    Revenue and Margins

    The operating margin was 16.4% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $109.38M, a compound annual rate of 2.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$137.39M-4.0%100.0%16.4%8.4%
    Dec 2024$143.06M-3.7%100.0%24.6%17.3%
    Dec 2023$148.58M-2.0%100.0%27.0%20.8%
    Dec 2022$151.57M+2.4%100.0%30.7%21.0%
    Dec 2021$147.95M+11.0%100.0%34.0%25.3%
    Dec 2020$133.28M+4.1%100.0%32.0%28.0%
    Dec 2019$127.98M+6.9%100.0%33.6%25.3%
    Dec 2018$119.69M+1.8%100.0%29.5%25.1%
    Dec 2017$117.56M+7.5%100.0%29.1%19.5%
    Dec 2016$109.38MN/A100.0%28.5%18.8%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 53.2% from the year before. In the quarter ended Sep 2026, net income rose 14.1% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$137.39M$143.06M$148.58M$151.57M$147.95M$133.28M$127.98M$119.69M$117.56M$109.38M
    Gross profit$137.39M$143.06M$148.58M$151.57M$147.95M$133.28M$127.98M$119.69M$117.56M$109.38M
    Operating income$22.59M$35.19M$40.05M$46.54M$50.27M$42.68M$43.03M$35.27M$34.22M$31.20M
    Net income$11.60M$24.78M$30.97M$31.80M$37.47M$37.26M$32.41M$30.05M$22.94M$20.52M
    EBITDA$30.22M$41.21M$45.94M$49.13M$56.65M$50.77M$48.11M$41.62M$38.85M$35.72M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$38.40M$35.39M$34.80M$35.19M$34.61M$34.04M$33.55M$36.91M$35.82M$35.02M$35.31M$38.00M
    Gross profit$38.40M$35.39M$34.80M$35.19M$34.61M$34.04M$33.55M$36.91M$35.82M$35.02M$35.31M$38.00M
    Operating income$8.91M-$3.24M$5.57M$4.67M$7.74M$1.59M$8.60M$9.59M$7.98M$8.87M$8.76M$11.71M
    Net income$4.70M-$3.28M$3.22M$1.80M$4.12M-$106.00K$5.79M$6.56M$5.69M$6.17M$6.36M$8.86M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $79.03M exceeded cash and equivalents by $74.90M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$134.88M$132.54M$122.44M$130.46M$157.54M$133.42M$110.69M$108.03M$127.32M$120.62M
    Current assets$20.21M$19.60M$24.36M$43.72M$73.71M$54.11M$29.16M$28.41M$52.26M$47.06M
    Cash and equivalents$4.14M$4.23M$6.65M$25.03M$54.36M$34.69M$13.52M$12.99M$34.73M$33.02M
    Total liabilities$120.89M$101.25M$73.48M$58.43M$72.20M$69.11M$77.79M$88.95M$37.27M$37.82M
    Short-term debt$4.01M$4.79M$7.21M$4.49M$4.28M$4.06M$4.38M$3.67M$1.14M$2.77M
    Long-term debt$75.02M$57.90M$29.47M$17.69M$22.27M$26.55M$29.80M$34.18M$0$857.00K
    Shareholder equity$13.99M$31.28M$48.95M$72.03M$85.34M$64.31M$32.89M$19.08M$90.04M$82.81M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$139.21M$136.15M$134.56M$134.88M$135.72M$141.39M$135.18M$132.54M$131.80M$119.10M$120.91M$122.44M
    Total liabilities$148.34M$129.60M$121.06M$120.89M$121.41M$120.06M$105.50M$101.25M$97.17M$78.90M$83.97M$73.48M
    Cash and equivalents$3.63M$3.33M$2.55M$4.14M$2.22M$5.27M$2.50M$4.23M$3.46M$485.00K$1.70M$6.65M
    Shareholder equity-$9.12M$6.55M$13.49M$13.99M$14.31M$21.33M$29.67M$31.28M$34.62M$40.20M$36.95M$48.95M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 59.5% of operating cash flow. Dividends and share repurchases together came to 198.0% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$26.45M$34.63M$38.11M$36.27M$46.34M$40.64M$40.92M$39.85M$28.09M$26.84M
    Capital expenditures$10.71M$15.45M$15.78M$9.84M$5.51M$3.98M$4.66M$5.97M$4.57M$3.97M
    Free cash flow$15.74M$19.18M$22.33M$26.43M$40.83M$36.65M$36.26M$33.88M$23.52M$22.87M
    Dividends paid$10.98M$11.45M$36.37M$20.96M$9.16M$10.52M$31.30M$16.86M$16.87M$30.55M
    Share repurchases$20.18M$30.95M$19.10M$27.62M$4.14M$0$0N/AN/AN/A
    Investing cash flow-$10.71M-$20.28M-$15.78M-$9.84M-$8.51M-$3.72M-$4.66M-$5.97M-$6.12M-$3.75M
    Financing cash flow-$15.84M-$16.76M-$40.71M-$55.58M-$18.16M-$15.50M-$36.35M-$54.50M-$21.12M-$32.50M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$8.02M$1.39M$7.18M$7.18M$13.76M-$1.14M$6.65M$6.38M$9.42M$6.79M$12.04M$11.71M
    Capital expenditures$1.04M$1.32M$1.83M$1.12M$3.59M$3.01M$2.99M$4.44M$1.60M$5.27M$4.14M$3.77M
    Free cash flow$6.98M$62.00K$5.35M$6.06M$10.18M-$4.15M$3.66M$1.94M$7.83M$1.52M$7.90M$7.94M
    Last 12 quarters

    Frequently Asked Questions About NRC

    What is NRC Health's annual revenue?

    NRC Health reported revenue of $137.39M for the fiscal year ended Dec 31, 2025.

    How fast is NRC Health's revenue growing?

    Revenue was down 4.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -3.2%.

    Is NRC Health profitable?

    Yes. NRC Health reported net income of $11.60M for the fiscal year ended Dec 31, 2025, with a net margin of 8.4%.

    How much free cash flow does NRC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $26.45M minus capital expenditures of $10.71M produced free cash flow of $15.74M.

    How much debt does NRC Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $75.02M, short-term debt of $4.01M and cash and equivalents of $4.14M.